Irinotecan plus gemcitabine and 5-fluorouracil in advanced pancreatic cancer: a phase II study.

Abstract

AIMS The aim of the present study was to evaluate the 6-month survival rate of patients with inoperable or metastatic pancreatic cancer treated with irinotecan and gemcitabine plus 5-fluorouracil. Secondary efficacy end points included response rate, time to progression (TTP), overall survival (OS) and toxicity. PATIENTS AND METHODS 30 patients with… (More)
DOI: 10.1159/000113039

Topics

3 Figures and Tables

Cite this paper

@article{Endlicher2007IrinotecanPG, title={Irinotecan plus gemcitabine and 5-fluorouracil in advanced pancreatic cancer: a phase II study.}, author={Esther Endlicher and Martina Troppmann and Annie Kullmann and Seana Golder and Thomas Herold and Hans H. Herfarth and Jonas Grossmann and Klaus Schlottmann and F Aura Kullmann}, journal={Oncology}, year={2007}, volume={72 5-6}, pages={279-84} }